by
Delaney Bryne
| Aug 31, 2026
Dermatologic surgery has evolved significantly over the past several decades. Among its most refined procedures, Mohs micrographic surgery (MMS) stands as the gold standard for the treatment of many cutaneous malignancies, offering exceptional cure rates while preserving as much healthy tissue as possible. It uniquely positions the surgeon as both the operating physician and the pathologist, ensuring complete histological margin clearance in a single outpatient session.
What makes MMS particularly advanced is its reliance on precise cryosurgical technique. Every stage of the procedure depends on controlled freezing and careful histological processing. This article discusses the specialized cryosurgical applications within MMS, including dermatologic indications, tissue processing protocols, staining methods, and immunohistochemical strategies that elevate the accuracy of this procedure.
Mohs Micrographic Surgery: Specialized Dermatologic Applications
MMS is not limited to basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Its applications have expanded significantly. It is now used to treat dermatofibrosarcoma protuberans, microcystic adnexal carcinoma, and sebaceous carcinoma. More recently, with the availability of reliable immunohistochemical stains, MMS has demonstrated strong utility in treating melanoma in situ, lentigo maligna, and thin invasive melanomas.
The Mohs Appropriate Use Criteria (AUC) helps guide clinicians in determining whether MMS is suitable for a given malignancy. The criteria consider factors such as lesion size, anatomical location, immune status, histological features, and whether the lesion is primary or recurrent. A score between 7 and 9 generally indicates MMS is appropriate. This system ensures that patients receive the right level of surgical intervention based on clinical need.
Cryosurgical Tissue Processing Techniques
The cryosurgical preparation of tissue is central to the success of MMS. After excision, the surgeon manipulates the specimen so that both peripheral and deep margins lie in the same plane. The specimen is then mounted on a cryostat chuck, frozen, and sectioned horizontally with a microtome blade. This is a method that allows 100% of the surgical margins to be examined in a single section.
Freezing temperature plays a critical role. Standard tissue is frozen at approximately −7.6°F. Adipose-rich specimens require colder temperatures, typically between −18.4°F and −25.6°F, to prevent tearing during sectioning. Cartilage, by contrast, is optimally sectioned at slightly warmer temperatures, between 3.2°F and −7.6°F, due to its inelastic nature. Tissue containing fat may also benefit from the use of a Peltier plate set to −58°F or a cryogen spray like liquid nitrogen.
Key steps during cryosurgical processing include:
- Specimen orientation: Small incisions mark the 12-o'clock position before excision to maintain directional accuracy throughout processing
- Bevel angle control: The scalpel is angled at approximately 45 degrees during excision to help the peripheral margin lie flat; angles below 30 degrees risk cutting into the tumor
- Relaxing incisions: Superficial vertical or beveled incisions help the tissue lie flat before embedding, without disrupting marginal surfaces
- Cryogen application: A liquid nitrogen spray can be used to secure the tissue onto the slide. This is especially useful for specimens that resist lying flat
Histology Preparation and Staining Protocols in Mohs Micrographic Surgery
Once frozen sections are cut to the appropriate thickness, typically 5 to 6 µm, staining begins. Hematoxylin and eosin (H&E) is the most widely used stain in MMS. Hematoxylin marks acidic cellular structures, such as nucleic acids, in a bluish-purple hue. Eosin provides a pink counterstain for cytoplasm and collagen.
Toluidine blue serves as an effective alternative, particularly for BCC. It stains tumor islands blue and the surrounding mucinous stroma a reddish-purple, making it easier to distinguish malignant tissue from adnexal structures. While faster and simpler than H&E, toluidine blue offers less nuclear detail and is therefore used in selective cases. Consistent, well-executed staining protocols are essential, as processing errors can lead to misinterpretation of margins and unnecessary tissue removal.
Immunohistochemistry in Frozen Section Analysis
Immunohistochemical (IHC) staining has become increasingly important in MMS, particularly for melanocytic tumors. MART-1 (melanoma antigen recognized by T cells 1) is the most commonly used immunostain for detecting melanoma in situ and minimally invasive melanoma on the face, ears, hands, and feet. It offers high sensitivity and specificity on frozen sections and is regarded as the most effective single stain for most melanoma variants.
A 20-minute rapid MART-1 protocol exists for efficient intraoperative use, involving cutting at 4 µm, acetone fixation, protein blocking, antibody application, and hematoxylin counterstaining. Additional melanocyte immunostains such as SOX10, Mel-5, HMB-45, PRAME, and S100 provide supplementary options for complex or unusual cases. Cytokeratin staining (e.g., AE1/AE3) is also available for SCC and BCC margin confirmation, though its added time and cost make H&E more practical for routine use.
Precision Tools for Precise Procedures: How Brymill Supports MMS Practice
MMS demands exact temperature control, reliable cryogen delivery, and consistent performance at every step. The cryogen spray used during tissue processing must deliver accurate, controlled output. Any inconsistency introduces risk.
Brymill Cryogenic Systems has been designing and manufacturing hand-held liquid nitrogen cryosurgical equipment since 1966. Our flagship Cry-Ac® and Cry-Ac®-3 devices are trusted by dermatologists for their precision, durability, and ease of use in clinical and laboratory settings.
For practices seeking equipment that meets the demands of advanced dermatologic procedures, contact us to learn more about how Brymill's solutions can support your MMS protocols.